The core activity of BioInnovas AG is the development, manufacture and distribution of products and solutions for quality assurance in nuclear medicine, PET centers, oligonucleotide synthesis, purification, cytometry and radiolabeling. This also includes providing instruments and solutions for the detection of radiolabels, the synthesis of radiolabeled compounds, the purification and modification of oligonucleotides, DNA and proteins, as well as cell analysis.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Reagents, solvents, moisture-control solutions, and phosphoramidites for automated oligonucleotide synthesis, complemented by oligo purification and scalable quantities for research and industry.
Biomolecule Purification
Chromatography resins and accessories for protein, antibody, enzyme, and nucleic acid purification, including desalting, buffer exchange, and gravity, FPLC, and centrifugation workflows.
Dyes & Labeling
Products for protein labeling, fluorescent dyes, and redox markers, complemented by labels, quenchers, and quick kits for precise detection and labeling applications.
Fine Chemicals
Buffers for oligonucleotide synthesis and purification.
Knowledge
No knowledge articles yet
Once BioInnovas AG has claimed this profile, we'll publish editorial articles and case studies here together.